Pancreatic Trials

Trial No.: ARMO AM0010-301 ARTIST 1

Trial Name:

A Randomized Phase 3 Study of AM0010 in Combination with FOLFOX Compared with FOLFOX Alone as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer that Have Progressed During or Following a First-Line Gemcitabine Containing Regimen

Trial No.: Halozyme HALO-109-301

Trial Name:

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) in Combination with nab-Paclitaxel Plus Gemcitabine Compared with Placebo Plus nab-Paclitaxel and Gemcitabine in Subjects with Hyaluranan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma

Fort Wayne North Office
(260) 484-8830
11143 Parkview Plaza Drive, Suite 100
Fort Wayne, Indiana 46845

Fort Wayne South Office
(260) 436-0800
7910 West Jefferson Boulevard, Suite 108
Fort Wayne, Indiana 46804

©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.